Developing new cancer drugs, Improving patients' lives

We focus on developing new drugs and formulations and prioritizing medications for cancers that are in high demand and difficult to treat.

About LaunXP

Innovator in cancer drug development

LaunXP focuses on developing new drugs and formulations, prioritizing medications that meet market needs and target hard-to-treat cancers.

In addition to pharmaceutical development, we are also developing biologic therapy. We are expecting for increasing therapeutic effect of pharmaceutical through precise drug delivery.
 

We are looking forward to providing more efficiency of therapies and improving the quality of life.

More about us
LAUNXP

R & D Projects

Three-track innovation strategy

505(b)(1)

Search new indications for carcinoma from medicines for chronic disease

505(b)(2)

Develop new chemical entities (NCE) for tumor therapies

Virus-like particle (VLP)

Research is underway on virus-like particles and nano-formulation anticancer drugs

Learn more

News

More News
More News

Get in Touch

Fill out the form, and we will contact you as soon as possible

Launxp Logo

Developing new cancer drugs. Improving patients' life.

Linkedin
Links
Investors
Get In Touch

Room B1, 10F., No. 51
Section 2, Gongyi Rd.
Nantun Dist. 408
Taichung City, Taiwan 

  • lxp@launxp.com
  • 04-2320-5691

© LaunXP Biomedical Co., Ltd.

Design: UThink Med Visuals